Efficacy and Safety of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use during Ramadan Fasting: A Systematic Review
Abstract: Background Religious intermittent fasting for 30 days during Ramadan may increase the risk of dehydration, hypovolemia, and hypoglycemia. These events may also be encountered when using sodium-glucose cotransporter 2 inhibitors (SGLT2is). Objectives This article evaluates the safety of the SGLT2 inhibitors in people with type 2 diabetes during Ramadan. Search Methods We searched PubMed CENTRAL, MEDLINE, and Google Scholar on July 25, 2023 without language restrictions. Selection Criteria All trials assessing the safety of SGLT2 inhibitors during Ramadan were assessed and summarized into preset points. Data Extraction Two authors independently extracted and reviewed the retrieved studies. A third author reviewed the merged summary of the two authors and modified the article when necessary. Results Diabetic ketoacidosis, hospitalization due to diabetes-related problems, and thrombosis were either not significantly related to SGLT2i use or not studied. Estimated glomerular filtration rate (eGFR) dropped significantly in one study; otherwise, it was either not statistically significant or not studied. Hypovolemia and dehydration were significantly increased in one study only. Conclusion From the available evidence, the use of SGLT2 inhibitors in people with diabetes during Ramadan seems to be safe and well tolerated. Hypovolemia and a drop in eGFR were reported in a few studies, with no reported clinical significance.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Efficacy and Safety of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use during Ramadan Fasting: A Systematic Review ; volume:07 ; number:04 ; year:2024 ; pages:176-184
Journal of diabetes & endocrine practice ; 07, Heft 04 (2024), 176-184
- Beteiligte Personen und Organisationen
- DOI
-
10.1055/s-0044-1791484
- URN
-
urn:nbn:de:101:1-2501231026393.427368472244
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:37 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abdelgadir, Elamin
- Bashier, Alaaeldin
- Ashfaq, Faryal
- Hassanein, Mohamed
- Beshyah, Salem
Ähnliche Objekte (12)
Diabetes, Kidneys, Heart, and Ramadan
COVID-19, Ramadan, diabetes, thyroid, and more
Intermittent Fasting, Ramadan Fasting, and Nutrition in the Elderly
IDF-DAR practical guidelines for management of diabetes during ramadan
High-risk patients observing ramadan fasting: More data and more insights!
Use of sodium-glucose co-transporter 2 inhibitors during the fasting of ramadan: Is there cause for concern?
Highlights of the Ninth Diabetes and Ramadan International Alliance conference (mena-zone virtual), January 21–22, 2021
JDEP at Seven Years of Age
A dedicated issue for a special congress!
The Giant of Tripoli: The Case of Late Recognition and Management of an Extreme Acromegalic Gigantism in Resource-Poor Settings
An Old Theme and New Technology: Marked Glucocorticoid-Induced Hyperglycemia in a Hospitalized Patient Uncovered Retrospectively by Her Flash Glucose Monitoring
The New Year's Message
Diabetes, Kidneys, Heart, and Ramadan
COVID-19, Ramadan, diabetes, thyroid, and more
Intermittent Fasting, Ramadan Fasting, and Nutrition in the Elderly
IDF-DAR practical guidelines for management of diabetes during ramadan
High-risk patients observing ramadan fasting: More data and more insights!
Use of sodium-glucose co-transporter 2 inhibitors during the fasting of ramadan: Is there cause for concern?
Highlights of the Ninth Diabetes and Ramadan International Alliance conference (mena-zone virtual), January 21–22, 2021
JDEP at Seven Years of Age
A dedicated issue for a special congress!
The Giant of Tripoli: The Case of Late Recognition and Management of an Extreme Acromegalic Gigantism in Resource-Poor Settings
An Old Theme and New Technology: Marked Glucocorticoid-Induced Hyperglycemia in a Hospitalized Patient Uncovered Retrospectively by Her Flash Glucose Monitoring
The New Year's Message
Diabetes, Kidneys, Heart, and Ramadan
COVID-19, Ramadan, diabetes, thyroid, and more
Intermittent Fasting, Ramadan Fasting, and Nutrition in the Elderly
IDF-DAR practical guidelines for management of diabetes during ramadan
High-risk patients observing ramadan fasting: More data and more insights!
Use of sodium-glucose co-transporter 2 inhibitors during the fasting of ramadan: Is there cause for concern?
Highlights of the Ninth Diabetes and Ramadan International Alliance conference (mena-zone virtual), January 21–22, 2021
JDEP at Seven Years of Age
A dedicated issue for a special congress!
The Giant of Tripoli: The Case of Late Recognition and Management of an Extreme Acromegalic Gigantism in Resource-Poor Settings
An Old Theme and New Technology: Marked Glucocorticoid-Induced Hyperglycemia in a Hospitalized Patient Uncovered Retrospectively by Her Flash Glucose Monitoring